Complement in glomerular diseases

Nephrology (Carlton). 2018 Oct:23 Suppl 4:11-15. doi: 10.1111/nep.13461.

Abstract

Complement activation has been identified to play a vital role in the pathogenesis of many glomerulonephritis, either as direct complement activation-driven factor in thrombotic microangiopathy and C3 glomerulopathy, and/or as an important contributor in lupus nephritis and anti-neutrophil cytoplasmic antibody-associated vasculitis. Recent studies indicated that complement activation may also play roles in the pathogenesis of immunoglobulin A nephropathy and focal segmental glomerulosclerosis. Interestingly, monoclonal immunoglobulins/light chains from patients with monoclonal gammopathy may interfere with complement activation and thus indirectly result in complement-mediated glomerulonephritis. Understanding of the pathogenic roles of complement activation in various glomerulonephritis will facilitate the identification of potential novel therapeutic targets in complement system.

Keywords: Complement; Glomerular disease; Pathogenesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Complement Activation* / drug effects
  • Complement Inactivating Agents / therapeutic use
  • Complement System Proteins / immunology*
  • Complement System Proteins / metabolism
  • Humans
  • Kidney Diseases / drug therapy
  • Kidney Diseases / immunology*
  • Kidney Glomerulus / immunology*
  • Kidney Glomerulus / metabolism
  • Kidney Glomerulus / pathology
  • Prognosis
  • Risk Factors

Substances

  • Complement Inactivating Agents
  • Complement System Proteins